Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VA › WOODSTOCK › SHENANDOAH MEMORIAL HOSPITAL, INC.

SHENANDOAH MEMORIAL HOSPITAL, INC.

NPI: 1033166442 · WOODSTOCK, VA 22664 · Critical Access Hospital · NPI assigned 05/30/2006

$23.55M
Total Medicaid Paid
379,385
Total Claims
307,265
Beneficiaries
177
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHEATER, FLOYD (PRESIDENT)
NPI Enumeration Date05/30/2006

Related Entities

Other providers sharing the same authorized official: HEATER, FLOYD

ProviderCityStateTotal Paid
SHENANDOAH MEMORIAL HOSPITAL WOODSTOCK VA $2.07M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 28,212 $970K
2019 42,651 $2.01M
2020 41,917 $2.47M
2021 58,027 $3.62M
2022 65,726 $4.44M
2023 75,641 $5.13M
2024 67,211 $4.91M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 22,190 20,053 $5.19M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 11,926 10,391 $3.11M
96361 Intravenous infusion, hydration; each additional hour 6,098 5,266 $2.55M
99284 Emergency department visit for the evaluation and management, high severity 9,630 8,667 $2.40M
74177 Computed tomography, abdomen and pelvis; with contrast material 3,652 3,411 $1.42M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 18,689 5,546 $1.36M
97530 Therapeutic activities, direct patient contact, each 15 minutes 13,383 4,269 $911K
70450 Computed tomography, head or brain; without contrast material 2,495 2,363 $743K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,953 2,771 $618K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 7,751 7,292 $598K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2,433 719 $486K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,939 1,477 $382K
74176 Computed tomography, abdomen and pelvis; without contrast material 976 930 $370K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 7,304 2,776 $350K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,622 1,520 $320K
97161 1,107 1,065 $215K
97162 853 823 $183K
87428 6,740 6,387 $146K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 19,808 18,378 $145K
71275 Computed tomographic angiography, chest, with contrast material 318 303 $142K
71046 Radiologic examination, chest; 2 views 4,645 4,407 $123K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,867 1,180 $123K
80053 Comprehensive metabolic panel 17,635 15,452 $111K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 320 251 $107K
97535 Self-care/home management training, each 15 minutes 1,136 771 $83K
G0378 Hospital observation service, per hour 275 235 $78K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,290 1,106 $68K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 500 458 $61K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 102 85 $56K
73564 1,409 1,299 $51K
77067 Screening mammography, bilateral, including computer-aided detection 603 593 $49K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,244 2,025 $49K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 8,779 7,733 $47K
73110 1,006 906 $41K
84443 Thyroid stimulating hormone (TSH) 4,154 3,957 $41K
36415 Collection of venous blood by venipuncture 19,514 16,178 $41K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 20,852 17,735 $35K
73610 1,046 964 $35K
73030 981 926 $34K
76830 Ultrasound, transvaginal 197 191 $34K
76705 Ultrasound, abdominal, real time with image documentation; limited 221 212 $32K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,667 6,698 $32K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,137 1,098 $29K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 7,583 3,568 $28K
80048 Basic metabolic panel (calcium, ionized) 3,628 3,169 $28K
73630 1,012 916 $26K
80061 Lipid panel 2,055 1,987 $25K
73130 966 863 $24K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 425 376 $22K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 59 56 $20K
81025 4,093 3,821 $16K
85379 2,298 2,162 $16K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 83 77 $16K
83036 Hemoglobin; glycosylated (A1C) 1,774 1,720 $15K
87420 676 631 $14K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 385 329 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1,424 1,310 $14K
87807 1,765 1,636 $13K
73502 309 285 $13K
81002 3,929 3,746 $13K
83880 792 726 $10K
87040 1,098 817 $9K
85610 2,703 1,886 $9K
77063 Screening digital breast tomosynthesis, bilateral 219 214 $9K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2,179 2,003 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 29 26 $8K
81003 5,418 5,072 $8K
72125 Computed tomography, cervical spine; without contrast material 192 186 $7K
72110 111 110 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 13 12 $7K
72100 138 137 $6K
80143 1,020 946 $6K
97163 71 70 $6K
84484 5,182 4,267 $6K
87086 Culture, bacterial; quantitative colony count, urine 3,585 3,303 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 294 291 $6K
71045 Radiologic examination, chest; single view 4,003 3,703 $5K
87634 306 299 $5K
73562 84 82 $5K
97165 12 12 $5K
92523 13 13 $5K
76536 25 24 $4K
80306 2,668 2,477 $4K
J3490 Unclassified drugs 4,284 2,750 $4K
12001 12 12 $3K
87081 5,541 5,265 $3K
86140 1,100 1,008 $3K
96375 Therapeutic injection; each additional sequential IV push 5,367 4,576 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 306 299 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material 36 36 $3K
80179 945 880 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 13 12 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,516 2,087 $3K
90715 84 83 $2K
81001 8,883 8,030 $2K
82947 460 226 $2K
J1170 Injection, hydromorphone, up to 4 mg 2,676 2,091 $2K
72131 16 15 $2K
96376 1,806 1,357 $2K
84466 184 178 $2K
85652 640 589 $2K
J2704 Injection, propofol, 10 mg 1,813 1,627 $2K
87400 208 98 $2K
74018 58 55 $2K
97750 43 40 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 223 187 $2K
84703 3,227 2,985 $2K
83690 4,499 3,958 $1K
83540 202 196 $1K
85018 177 169 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 670 605 $1K
83735 1,089 913 $1K
73140 41 39 $999.22
J3010 Injection, fentanyl citrate, 0.1 mg 1,696 1,325 $980.33
87186 1,495 1,324 $937.73
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,263 1,182 $916.72
84145 196 171 $850.88
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 26 25 $801.90
82607 67 66 $692.42
J0131 Injection, acetaminophen, not otherwise specified,10 mg 716 682 $634.55
87070 480 428 $625.21
76801 13 12 $624.56
83605 1,480 1,212 $588.36
87077 824 745 $486.33
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 82 79 $470.01
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 14 14 $444.42
73620 27 25 $428.48
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,627 3,171 $410.39
73080 13 13 $400.14
80076 162 159 $352.70
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 82 79 $346.70
94664 707 646 $325.79
73090 27 25 $320.98
84439 43 41 $293.34
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,711 3,460 $293.08
J7050 Infusion, normal saline solution, 250 cc 2,242 1,144 $242.46
82948 1,235 752 $237.63
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 263 236 $232.86
80047 165 150 $223.98
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 297 281 $217.81
J0780 Injection, prochlorperazine, up to 10 mg 386 353 $217.46
83655 12 12 $216.83
J1885 Injection, ketorolac tromethamine, per 15 mg 2,367 2,041 $210.55
74019 13 13 $208.92
85730 258 237 $187.80
J2270 Injection, morphine sulfate, up to 10 mg 1,087 924 $185.05
85014 63 62 $173.32
82746 13 12 $158.10
87205 244 222 $130.52
74022 18 17 $99.49
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 16 15 $92.81
J2250 Injection, midazolam hydrochloride, per 1 mg 905 849 $91.93
87088 59 54 $91.08
82270 28 24 $73.65
94760 343 302 $58.31
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study 151 142 $50.40
82550 67 60 $45.14
85027 15 13 $44.53
J0696 Injection, ceftriaxone sodium, per 250 mg 850 746 $39.28
88305 Level IV - Surgical pathology, gross and microscopic examination 192 171 $35.80
J2060 Injection, lorazepam, 2 mg 167 131 $24.75
84702 29 25 $20.02
J1650 Injection, enoxaparin sodium, 10 mg 41 29 $8.05
J0690 Injection, cefazolin sodium, 500 mg 89 78 $5.46
J1200 Injection, diphenhydramine hcl, up to 50 mg 253 232 $2.25
J2795 Injection, ropivacaine hydrochloride, 1 mg 116 104 $0.32
J2003 Injection, lidocaine hydrochloride, 1 mg 17 15 $0.00
J8540 Dexamethasone, oral, 0.25 mg 28 25 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 126 90 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 29 29 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 45 42 $0.00
73600 14 14 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 29 28 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 49 44 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 44 38 $0.00
J1171 Injection, hydromorphone, 0.1 mg 70 50 $0.00
29125 14 14 $0.00